76 results on '"Rohana Yusof"'
Search Results
2. Menopause-Associated Depression: Impact of Oxidative Stress and Neuroinflammation on the Central Nervous System—A Review
- Author
-
Gengfan Liang, Audrey Siew Foong Kow, Rohana Yusof, Chau Ling Tham, Yu-Cheng Ho, and Ming Tatt Lee
- Subjects
estrogen deprivation ,psychological wellbeing ,pro-inflammatory cytokines ,Biology (General) ,QH301-705.5 - Abstract
Perimenopausal depression, occurring shortly before or after menopause, is characterized by symptoms such as emotional depression, anxiety, and stress, often accompanied by endocrine dysfunction, particularly hypogonadism and senescence. Current treatments for perimenopausal depression primarily provide symptomatic relief but often come with undesirable side effects. The development of agents targeting the specific pathologies of perimenopausal depression has been relatively slow. The erratic fluctuations in estrogen and progesterone levels during the perimenopausal stage expose women to the risk of developing perimenopausal-associated depression. These hormonal changes trigger the production of proinflammatory mediators and induce oxidative stress, leading to progressive neuronal damage. This review serves as a comprehensive overview of the underlying mechanisms contributing to perimenopausal depression. It aims to shed light on the complex relationship between perimenopausal hormones, neurotransmitters, brain-derived neurotrophic factors, chronic inflammation, oxidative stress, and perimenopausal depression. By summarizing the intricate interplay between hormonal fluctuations, neurotransmitter activity, brain-derived neurotrophic factors, chronic inflammation, oxidative stress, and perimenopausal depression, this review aims to stimulate further research in this field. The hope is that an increased understanding of these mechanisms will pave the way for the development of more effective therapeutic targets, ultimately reducing the risk of depression during the menopausal stage for the betterment of psychological wellbeing.
- Published
- 2024
- Full Text
- View/download PDF
3. Endoplasmic reticulum: a focal point of Zika virus infection
- Author
-
Muhammad Izzuddin Mohd Ropidi, Ahmad Suhail Khazali, Nurshamimi Nor Rashid, and Rohana Yusof
- Subjects
Zika virus ,Endoplasmic reticulum ,Unfolded protein response ,Stress granules ,Reticulophagy ,Paraptosis ,Medicine - Abstract
Abstract Zika virus (ZIKV) belongs to the Flavivirus genus of the Flaviviridae family. It is an arbovirus that can cause congenital abnormalities and is sexually transmissible. A series of outbreaks accompanied by unexpected severe clinical complications have captured medical attention to further characterize the clinical features of congenital ZIKV syndrome and its underlying pathophysiological mechanisms. Endoplasmic reticulum (ER) and ER-related proteins are essential in ZIKV genome replication. This review highlights the subcellular localization of ZIKV to the ER and ZIKV modulation on the architecture of the ER. This review also discusses ZIKV interaction with ER proteins such as signal peptidase complex subunit 1 (SPCS1), ER membrane complex (EMC) subunits, and ER translocon for viral replication. Furthermore, the review covers several important resulting effects of ZIKV infection to the ER and cellular processes including ER stress, reticulophagy, and paraptosis-like death. Pharmacological targeting of ZIKV-affected ER-resident proteins and ER-associated components demonstrate promising signs of combating ZIKV infection and rescuing host organisms from severe neurologic sequelae.
- Published
- 2020
- Full Text
- View/download PDF
4. Synthesized flavanoid-derived ligand reduced dengue virus type-2 replication in vitro
- Author
-
Mudiana Muhamad, Yean Kee Lee, Noorsaadah Abd. Rahman, and Rohana Yusof
- Subjects
Synthesized derived ligand ,Dengue replication ,Inhibition assay ,Quantitative RT-PCR ,Cytoskeletal actin tubulin distribution ,Arctic medicine. Tropical medicine ,RC955-962 ,Biology (General) ,QH301-705.5 - Abstract
Objective: To investigate the antiviral property of a lead ligand, YK51 that was synthesized based on the flavanoid of a natural product toward dengue virus type-2 (DENV2) replication. Methods: cRNA was isolated from HepG2 cells inoculated with 1000 median tissue culture infective dose of DENV2 and treated with different doses of the ligand followed by RT-PCR to quantify the virus gene copies. Confocal microscopy of actin and tubulin redistribution was also performed. Results: The quantitative RT-PCR result showed reduction of the DENV2 gene copies as the ligand concentration was increased. The confocal microscopy result showed increase in the tubulin intensity (79.6%) of infected BHK21 cells treated with the ligand, compared with the non-treated cells (54.8%). The 1.5-fold increase in the intensity of tubulin suggested that the ligand inhibitory effect stabilized the cellular microtubule structure. Conclusions: The synthesized ligand YK51 reduced DENV2 viral load by inhibiting virus replication thus is highly potential to be developed as antiviral agent.
- Published
- 2017
- Full Text
- View/download PDF
5. Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling.
- Author
-
Maywan Hariono, Sy Bing Choi, Ros Fatihah Roslim, Mohamed Sufian Nawi, Mei Lan Tan, Ezatul Ezleen Kamarulzaman, Nornisah Mohamed, Rohana Yusof, Shatrah Othman, Noorsaadah Abd Rahman, Rozana Othman, and Habibah A Wahab
- Subjects
Medicine ,Science - Abstract
Dengue virus Type 2 (DENV-2) is predominant serotype causing major dengue epidemics. There are a number of studies carried out to find its effective antiviral, however to date, there is still no molecule either from peptide or small molecules released as a drug. The present study aims to identify small molecules inhibitor from National Cancer Institute database through virtual screening. One of the hits, D0713 (IC50 = 62 μM) bearing thioguanine scaffold was derivatised into 21 compounds and evaluated for DENV-2 NS2B/NS3 protease inhibitory activity. Compounds 18 and 21 demonstrated the most potent activity with IC50 of 0.38 μM and 16 μM, respectively. Molecular dynamics and MM/PBSA free energy of binding calculation were conducted to study the interaction mechanism of these compounds with the protease. The free energy of binding of 18 calculated by MM/PBSA is -16.10 kcal/mol compared to the known inhibitor, panduratin A (-11.27 kcal/mol), which corroborates well with the experimental observation. Results from molecular dynamics simulations also showed that both 18 and 21 bind in the active site and stabilised by the formation of hydrogen bonds with Asn174.
- Published
- 2019
- Full Text
- View/download PDF
6. Development of a NS2B/NS3 protease inhibition assay using AlphaScreen® beads for screening of anti-dengue activities
- Author
-
Muhammad Asyraf Abduraman, Maywan Hariono, Rohana Yusof, Noorsaadah Abd Rahman, Habibah A. Wahab, and Mei Lan Tan
- Subjects
Bioinformatics ,Biotechnology ,Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
Background: Dengue infection is an endemic infectious disease and it can lead to dengue fever, dengue hemorrhagic fever, and/or dengue shock syndromes. Dengue NS2B/NS3 protease complex is essential for viral replication and is a primary target for anti-dengue drug development. In this study, a NS2B/NS3 protease inhibition assay was developed using AlphaScreen® beads and was used to screen compounds for their protease inhibition activities. Methods: The assay system utilized a known NS2B/NS3 peptide substrate, a recombinant of NS2B/NS3 protease with proprietary StrepTactin® donor and nickel chelate acceptor beads in 384-well format. Results: The optimized assay to screen for NS2B/NS3 protease inhibitors was demonstrated to be potentially useful with reasonable zʹ factor, coefficient variance and signal to background ratio. However, screening of synthesized thioguanine derivatives using the optimized AlphaScreen® assay revealed weak NS2B/NS3 inhibition activities. Conclusion: The AlphaScreen® assay to screen for NS2B/NS3 protease inhibitors is potentially applicable for high throughput screening.
- Published
- 2018
- Full Text
- View/download PDF
7. Comparative proteomics reveals that YK51, a 4-Hydroxypandurantin-A analogue, downregulates the expression of proteins associated with dengue virus infection
- Author
-
Wei-Lian Tan, Yean Kee Lee, Yen Fong Ho, Rohana Yusof, Noorsaadah Abdul Rahman, and Saiful Anuar Karsani
- Subjects
Dengue virus type-2 ,Proteomics ,Anti-viral compound ,Inhibitory activity ,Medicine ,Biology (General) ,QH301-705.5 - Abstract
Dengue is endemic throughout tropical and subtropical regions of the world. Currently, there is no clinically approved therapeutic drug available for this acute viral infection. Although the first dengue vaccine Dengvaxia has been approved for use in certain countries, it is limited to those without a previous dengue infection while the safety and efficacy of the vaccine in those elderly and younger children still need to be identified. Therefore, it is becoming increasingly important to develop therapeutics/drugs to combat dengue virus (DENV) infection. YK51 is a synthetic analogue of 4-Hydroxypandurantin A (a compound found in the crude extract of the rhizomes of Boesenbergia rotunda) that has been extensively studied by our research group. It has been shown to possess outstanding antiviral activity due to its inhibitory activity against NS2B/NS3 DENV2 protease. However, it is not known how YK51 affects the proteome of DENV infected cells. Therefore, we performed a comparative proteomics analysis to identify changes in protein expression in DENV infected HepG2 cells treated with YK51. Classical two-dimensional gel electrophoresis followed by protein identification using tandem mass spectrometry was employed in this study. Thirty proteins were found to be down-regulated with YK51 treatment. In silico analysis predicted that the down-regulation of eight of these proteins may inhibit viral infection. Our results suggested that apart from inhibiting the NS2B/NS3 DENV2 protease, YK51 may also be causing the down-regulation of a number of proteins that may be responsible in, and/or essential to virus infection. However, functional characterization of these proteins will be necessary before we can conclusively determine their roles in DENV infection.
- Published
- 2018
- Full Text
- View/download PDF
8. Development of a Passive Liquid Valve (PLV) Utilizing a Pressure Equilibrium Phenomenon on the Centrifugal Microfluidic Platform
- Author
-
Wisam Al-Faqheri, Fatimah Ibrahim, Tzer Hwai Gilbert Thio, Norulain Bahari, Hamzah Arof, Hussin A. Rothan, Rohana Yusof, and Marc Madou
- Subjects
centrifugal platform ,microfluidic CD ,passive liquid valve ,pressure equilibrium ,S-PLV ,D-PLV ,Chemical technology ,TP1-1185 - Abstract
In this paper, we propose an easy-to-implement passive liquid valve (PLV) for the microfluidic compact-disc (CD). This valve can be implemented by introducing venting chambers to control the air flow of the source and destination chambers. The PLV mechanism is based on equalizing the main forces acting on the microfluidic CD (i.e., the centrifugal and capillary forces) to control the burst frequency of the source chamber liquid. For a better understanding of the physics behind the proposed PLV, an analytical model is described. Moreover, three parameters that control the effectiveness of the proposed valve, i.e., the liquid height, liquid density, and venting chamber position with respect to the CD center, are tested experimentally. To demonstrate the ability of the proposed PLV valve, microfluidic liquid switching and liquid metering are performed. In addition, a Bradford assay is performed to measure the protein concentration and evaluated in comparison to the benchtop procedure. The result shows that the proposed valve can be implemented in any microfluidic process that requires simplicity and accuracy. Moreover, the developed valve increases the flexibility of the centrifugal CD platform for passive control of the liquid flow without the need for an external force or trigger.
- Published
- 2015
- Full Text
- View/download PDF
9. A Microfluidic Lab-on-a-Disc (LOD) for Antioxidant Activities of Plant Extracts
- Author
-
Nurhaslina Abd Rahman, Fatimah Ibrahim, Mohammad M. Aeinehvand, Rohana Yusof, and Marc Madou
- Subjects
Lab-on-a-Disc (LoD) ,centrifugal microfluidic CD ,plant antioxidant activity ,antioxidants ,DPPH ,Mechanical engineering and machinery ,TJ1-1570 - Abstract
Antioxidants are an important substance that can fight the deterioration of free radicals and can easily oxidize when exposed to light. There are many methods to measure the antioxidant activity in a biological sample, for example 2,2-diphenyl-1-picrylhydrazyl (DPPH) antioxidant activity test, which is one of the simplest methods used. Despite its simplicity, the organic solvent that has been used to dilute DPPH is easily evaporated and degraded with respect to light exposure and time. Thus, it needs to be used at the earliest convenient time prior to the experiment. To overcome this issue, a rapid and close system for antioxidant activity is required. In this paper, we introduced the Lab-on-a-Disc (LoD) method that integrates the DPPH antioxidant activity test on a microfluidic compact disc (CD). We used ascorbic acid, quercetin, Areca catechu, Polygonum minus, and Syzygium polyanthum plant extracts to compare the results of our proposed LoD method with the conventional method. Contrasted to the arduous laborious conventional method, our proposed method offer rapid analysis and simple determination of antioxidant. This proposed LoD method for antioxidant activity in plants would be a platform for the further development of antioxidant assay.
- Published
- 2018
- Full Text
- View/download PDF
10. Scalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional Chemotherapeutics.
- Author
-
Hussin A Rothan, Jamunaa Ambikabothy, Ammar Y Abdulrahman, Hirbod Bahrani, Mojtaba Golpich, Elham Amini, Noorsaadah A Rahman, Teow Chong Teoh, Zulqarnain Mohamed, and Rohana Yusof
- Subjects
Medicine ,Science - Abstract
The production of short anticancer peptides in recombinant form is an alternative method for costly chemical manufacturing. However, the limitations of host toxicity, bioactivity and column purification have impaired production in mass quantities. In this study, short cationic peptides were produced in aggregated inclusion bodies by double fusion with a central protein that has anti-cancer activity. The anticancer peptides Tachiplicin I (TACH) and Latarcin 1 (LATA) were fused with the N- and C-terminus of the MAP30 protein, respectively. We successfully produced the recombinant TACH-MAP30-LATA protein and MAP30 alone in E. coli that represented 59% and 68% of the inclusion bodies. The purified form of the inclusion bodies was prepared by eliminating host cell proteins through multiple washing steps and semi-solubilization in alkaline buffer. The purified active protein was recovered by inclusive solubilization at pH 12.5 in the presence of 2 M urea and refolded in alkaline buffer containing oxides and reduced glutathione. The peptide-fusion protein showed lower CC50 values against cancer cells (HepG2, 0.35±0.1 μM and MCF-7, 0.58±0.1 μM) compared with normal cells (WRL68, 1.83±0.2 μM and ARPE19, 2.5±0.1 μM) with outstanding activity compared with its individual components. The presence of the short peptides facilitated the entry of the peptide fusion protein into cancer cells (1.8 to 2.2-fold) compared with MAP30 alone through direct interaction with the cell membrane. The cancer chemotherapy agent doxorubicin showed higher efficiency and selectivity against cancer cells in combination with the peptide- fusion protein. This study provides new data on the mass production of short anticancer peptides as inclusion bodies in E. coli by fusion with a central protein that has similar activity. The product was biologically active against cancer cells compared with normal cells and enhanced the activity and selective delivery of an anticancer chemotherapy agent.
- Published
- 2015
- Full Text
- View/download PDF
11. A combination of doxycycline and ribavirin alleviated chikungunya infection.
- Author
-
Hussin A Rothan, Hirbod Bahrani, Zulqarnain Mohamed, Teow Chong Teoh, Esaki M Shankar, Noorsaadah A Rahman, and Rohana Yusof
- Subjects
Medicine ,Science - Abstract
Lack of vaccine and effective antiviral drugs against chikungunya virus (CHIKV) outbreaks have led to significant impact on health care in the developing world. Here, we evaluated the antiviral effects of tetracycline (TETRA) derivatives and other common antiviral agents against CHIKV. Our results showed that within the TETRA derivatives group, Doxycycline (DOXY) exhibited the highest inhibitory effect against CHIKV replication in Vero cells. On the other hand, in the antiviral group Ribavirin (RIBA) showed higher inhibitory effects against CHIKV replication compared to Aciclovir (ACIC). Interestingly, RIBA inhibitory effects were also higher than all but DOXY within the TETRA derivatives group. Docking studies of DOXY to viral cysteine protease and E2 envelope protein showed non-competitive interaction with docking energy of -6.6±0.1 and -6.4±0.1 kcal/mol respectively. The 50% effective concentration (EC50) of DOXY and RIBA was determined to be 10.95±2.12 μM and 15.51±1.62 μM respectively, while DOXY+RIBA (1:1 combination) showed an EC50 of 4.52±1.42 μM. When compared, DOXY showed higher inhibition of viral infectivity and entry than RIBA. In contrast however, RIBA showed higher inhibition against viral replication in target cells compared to DOXY. Assays using mice as animal models revealed that DOXY+RIBA effectively inhibited CHIKV replication and attenuated its infectivity in vivo. Further experimental and clinical studies are warranted to investigate their potential application for clinical intervention of CHIKV disease.
- Published
- 2015
- Full Text
- View/download PDF
12. Differential Analysis of the Secretome of WRL68 Cells Infected with the Chikungunya Virus.
- Author
-
Christina Li-Ping Thio, Rohana Yusof, Ali Ashrafzadeh, Syareena Bahari, Puteri Shafinaz Abdul-Rahman, and Saiful Anuar Karsani
- Subjects
Medicine ,Science - Abstract
The Chikungunya virus (CHIKV) is an arthropod borne virus. In the last 50 years, it has been the cause of numerous outbreaks in tropical and temperate regions, worldwide. There is limited understanding regarding the underlying molecular mechanisms involved in CHIKV replication and how the virus interacts with its host. In the present study, comparative proteomics was used to identify secreted host proteins that changed in abundance in response to early CHIKV infection. Two-dimensional gel electrophoresis was used to analyse and compare the secretome profiles of WRL-68 cells infected with CHIKV against mock control WRL-68 cells. The analysis identified 25 regulated proteins in CHIKV infected cells. STRING network analysis was then used to predict biological processes that may be affected by these proteins. The processes predicted to be affected include signal transduction, cellular component and extracellular matrix (ECM) organization, regulation of cytokine stimulus and immune response. These results provide an initial view of CHIKV may affect the secretome of infected cells during early infection. The results presented here will compliment earlier results from the study of late host response. However, functional characterization will be necessary to further enhance our understanding of the roles played by these proteins in the early stages of CHIKV infection in humans.
- Published
- 2015
- Full Text
- View/download PDF
13. Fusion of protegrin-1 and plectasin to MAP30 shows significant inhibition activity against dengue virus replication.
- Author
-
Hussin A Rothan, Hirbod Bahrani, Zulqarnain Mohamed, Noorsaadah Abd Rahman, and Rohana Yusof
- Subjects
Medicine ,Science - Abstract
Dengue virus (DENV) broadly disseminates in tropical and sub-tropical countries and there are no vaccine or anti-dengue drugs available. DENV outbreaks cause serious economic burden due to infection complications that requires special medical care and hospitalization. This study presents a new strategy for inexpensive production of anti-DENV peptide-fusion protein to prevent and/or treat DENV infection. Antiviral cationic peptides protegrin-1 (PG1) and plectasin (PLSN) were fused with MAP30 protein to produce recombinant antiviral peptide-fusion protein (PG1-MAP30-PLSN) as inclusion bodies in E. coli. High yield production of PG1-MAP30-PLSN protein was achieved by solubilization of inclusion bodies in alkaline buffer followed by the application of appropriate refolding techniques. Antiviral PG1-MAP30-PLSN protein considerably inhibited DENV protease (NS2B-NS3pro) with half-maximal inhibitory concentration (IC50) 0.5±0.1 μM. The real-time proliferation assay (RTCA) and the end-point proliferation assay (MTT assay) showed that the maximal-nontoxic dose of the peptide-fusion protein against Vero cells is approximately 0.67±0.2 μM. The cell-based assays showed considerable inhibition of the peptide-fusion protein against binding and proliferating stages of DENV2 into the target cells. The peptide-fusion protein protected DENV2-challeged mice with 100% of survival at the dose of 50 mg/kg. In conclusion, producing recombinant antiviral peptide-fusion protein by combining short antiviral peptide with a central protein owning similar activity could be useful to minimize the overall cost of short peptide production and take advantage of its synergistic antiviral activities.
- Published
- 2014
- Full Text
- View/download PDF
14. Differential proteome analysis of chikungunya virus infection on host cells.
- Author
-
Christina Li-Ping Thio, Rohana Yusof, Puteri Shafinaz Akmar Abdul-Rahman, and Saiful Anuar Karsani
- Subjects
Medicine ,Science - Abstract
BACKGROUND: Chikungunya virus (CHIKV) is an emerging mosquito-borne alphavirus that has caused multiple unprecedented and re-emerging outbreaks in both tropical and temperate countries. Despite ongoing research efforts, the underlying factors involved in facilitating CHIKV replication during early infection remains ill-characterized. The present study serves to identify host proteins modulated in response to early CHIKV infection using a proteomics approach. METHODOLOGY AND PRINCIPAL FINDINGS: The whole cell proteome profiles of CHIKV-infected and mock control WRL-68 cells were compared and analyzed using two-dimensional gel electrophoresis (2-DGE). Fifty-three spots were found to be differentially modulated and 50 were successfully identified by MALDI-TOF/TOF. Eight were significantly up-regulated and 42 were down-regulated. The mRNA expressions of 15 genes were also found to correlate with the corresponding protein expression. STRING network analysis identified several biological processes to be affected, including mRNA processing, translation, energy production and cellular metabolism, ubiquitin-proteasome pathway (UPP) and cell cycle regulation. CONCLUSION/SIGNIFICANCE: This study constitutes a first attempt to investigate alteration of the host cellular proteome during early CHIKV infection. Our proteomics data showed that during early infection, CHIKV affected the expression of proteins that are involved in mRNA processing, host metabolic machinery, UPP, and cyclin-dependent kinase 1 (CDK1) regulation (in favour of virus survival, replication and transmission). While results from this study complement the proteomics results obtained from previous late host response studies, functional characterization of these proteins is warranted to reinforce our understanding of their roles during early CHIKV infection in humans.
- Published
- 2013
- Full Text
- View/download PDF
15. Subversion of immunoproteasome subunit expression in dengue virus serotype 2-infected HepG2 cells
- Author
-
Chye Sheng Gan, Pei Jean Lim, Muhammad Fazril Mohamad Razif, Rohana Yusof, and Shatrah Othman
- Subjects
Dengue virus ,LMP2 ,LMP7 ,Arctic medicine. Tropical medicine ,RC955-962 - Abstract
Abstract: INTRODUCTION: Infection with all serotypes of dengue virus (DV) results in augmented antigen presentation by MHC class I molecules. However, the upregulation of immunoproteasome subunits only results from infection with two serotypes. This study aims to elucidate changes in the expression of immunoproteasome subunits resulting from infection with DV, particularly DV serotype 2 (DV2). METHODS: HepG2 cells were grown in various culture milieu. Total cellular RNA and proteins were extracted and quantified. RESULTS: Results demonstrated sequestration of immunoproteasome subunits LMP2 and LMP7 in DV2-infected cells. CONCLUSIONS: This study provides insights into the mechanisms underlying immune evasion by DV.
- Full Text
- View/download PDF
16. Contributors
- Author
-
Tawfik Aboellail, Jônatas Santos Abrahão, Talita Adelino, Ramesh Akkina, Ayman Alboudi, Luiz Carlos Junior Alcantara, Henning Andersen, Teresinha De Jesus Aguiar Dos Santos Andrade, Masashi Arakawa, Josélio Maria Galvão de Araújo, Pamella Nunes Azevedo, Omar Bagasra, Mark J. Bailey, Serdar Baraklı, Alison Jane Basile, Luis Federico Bátiz, Benan Bayrakci, Aline Almeida Bentes, Jean A. Bernatchez, A.B. Blázquez, Viola Borchardt-Lohölter, Ana Luiza Vilela Borges, Maria Sole Burali, Felipe A. Bustamante-Barrientos, Paulo E. Cabral Filho, Steven Vargas Cañas, Talita Castro, Gwong-Jen J. Chang, Day-Yu Chao, Ameya Chaudhari, Duverney Chaverra-Rodriguez, Raissa R. Christoff, Luiz Felipe Leomil Coelho, Diogo Goulart Corrêa, Michael Coste, Raquel Zanatta Coutinho, Joaquim Soares da Costa Júnior, Anna Carolina Toledo da Cunha Pereira, Paulo Marcos da Matta Guedes, Guilherme Liberato da Silva, Jaderson Costa DaCosta, Prajakta Dandekar, Amos Danielli, Maria das Dores Alves de Oliveira, Orhan Deniz, Philippe Desprès, Betânia Paiva Drumond, Jonny Duque, Patrícia e Silva Alves, Chaker El Kalamouni, José Veríssimo Fernandes, Gustavo Portela Ferreira, T. Foiadelli, Vagner Fonseca, Adriana Fontes, Lawrence Frenkel, Gilles Gadea, Patricia P. Garcez, Marta Giovanetti, Fernando Gomez, Bonnie E. Gulas-Wroblewski, Şadiye Gümüşyayla, Sunam Gurung, Juliano G. Haddad, Thomas Harbo, Cecília Hedin-Pereira, Roberto Henzi, Holly R. Hughes, Luiz Celso Hygino da Cruz Júnior, Andrew Jameson, Rachel Jordan, Rebecca B. Kairis, Taruna Kaura, Selman Kesici, Ahmad Suhail Khazali, Julia Maria Klemens, Erna Geessien Kroon, Walter Sze Tung Lam, Erik Lattwein, Vladimir V. Lazarev, Túlio César Rodrigues Leite, Cui Li, Nerilson Marques Lima, Maria Elizabeth Lopes Moreira, Karina Carrillo Loza, Denise Cantarelli Machado, Fernanda Majolo, Luiz Cosme Cotta Malaquias, Giuseppe Manfroni, Daniel Rodrigo Marinowic, Dimitri Marques Abramov, G.L. Marseglia, Ewen McLean, Breno de Mello Silva, Stelia Mendez-Sanchez, Abhishek Mewara, Eiji Morita, Kristy O. Murray, Dean Myers, Manuela Sales Lima Nascimento, Osvaldo J.M. Nascimento, Marciano Viana Paes, James Papin, Giovannia A.L. Pereira, Goreti Pereira, Maria I.A. Pereira, Naveed Pervaiz, Byron W. Purse, Kíssila Rabelo, Jéssika F.F. Ribeiro, Shannon E. Ronca, Shira Roth, Tania Regina Saad Salles, Lívia Sacchetto, J.C. Saiz, Natália Gedeão Salomão, Beate S. Santos, Sandra Saschenbrecker, S. Savasta, Wolfgang Schlumberger, Kimberly Schmitt, Jair L. Siqueira-Neto, Derek Tuck Loong Soon, José Luis Soto-Hernández, Gabriel Augusto Pires de Souza, Katja Steinhagen, Konstanze Stiba, Paul Ananth Tambyah, Gene S. Tan, Stephane Tosta, C. Trabatti, Gönül Vural, Heron Werner, Joilson Xavier, Zhiheng Xu, Tay Wei Xuan, and Rohana Yusof
- Published
- 2022
- Full Text
- View/download PDF
17. Evaluation of neutralizing antibodies produced by papaya mosaic virus nanoparticles fused to the E2EP3 peptide epitope of Chikungunya envelope
- Author
-
Nurshamimi Nor Rashid, S J Al-Harbi, Rohana Yusof, Hussin A. Rothan, and Teow Chong Teoh
- Subjects
medicine.disease_cause ,Antibodies, Viral ,Virus ,Epitope ,Epitopes ,Viral Envelope Proteins ,medicine ,Animals ,Chikungunya ,Amino Acid Sequence ,Neutralizing antibody ,Mice, Inbred ICR ,biology ,virus diseases ,biology.organism_classification ,Virology ,Antibodies, Neutralizing ,Potexvirus ,Immunization ,biology.protein ,Vero cell ,Chikungunya Fever ,Nanoparticles ,Antibody ,Peptides ,Chikungunya virus ,Papaya mosaic virus - Abstract
Chikungunya virus (CHIKV) infection is the cause of acute symptoms and chronic symmetrical polyarthritis associated with long-term morbidity and mortality. Currently, there is no available licensed vaccine or particularly useful drug for human use against CHIKV infection. This study was conducted to evaluate the efficacy of antibodies produced by papaya mosaic virus (PapMV) nanoparticles fused to E2EP3 peptide of CHIKV envelope as a recombinant CHIKV vaccine. PapMV, PapMV-C- E2EP3, and E2EP3-N-PapMV were produced in E. coli with an approximate size of 27 to 30 kDa. ICR mice (5 to 6 weeks of age) were injected subcutaneously with 25 micrograms of vaccine construct, and ELISA measured the titer of CHIKV specific IgG antibodies. The results showed that both recombinant proteins E2EP3-N-PapMV and PapMVC-E2EP3 were able to induce IgG antibodies production in immunized mice against CHIKV while immunization with recombinant PapMV showed no IgG antibodies induction. The neutralizing activity of the antibodies generated by either E2EP3-N-PapMV or PapMV-C-E2EP3 exhibited similar inhibition to CHIKV replication in Vero cells using the cells based antibody neutralizing assay and analyzed by plaque formation assay. This study showed the effectiveness of nanoparticles vaccine generated by fusing epitope peptide of CHIKV envelope to papaya mosaic virus envelope in inducing a robust immune response in mice against CHIKV. The data showed that levels of neutralizing antibodies correlate with a protective immune response CHIKV replication.
- Published
- 2021
18. Discovery of small molecule inhibitors against the NS3/4A serine protease of Hepatitis C virus genotype 3 via highthroughput virtual screening and in vitro evaluations
- Author
-
Teow Chong Teoh, See Khai Lim, Rohana Yusof, M F M Razif, and W Sakhor
- Subjects
viruses ,In silico ,Hepatitis C virus ,Drug Evaluation, Preclinical ,Hepacivirus ,Biology ,Viral Nonstructural Proteins ,medicine.disease_cause ,Antiviral Agents ,Cell Line ,Genotype ,medicine ,Humans ,Protease Inhibitors ,ADME ,Serine protease ,NS3 ,Virtual screening ,Molecular Structure ,virus diseases ,Virology ,digestive system diseases ,Protein Structure, Tertiary ,Molecular Docking Simulation ,biology.protein ,Serine Proteases ,PubChem - Abstract
The hepatitis C virus (HCV) consists of eight genotypes and 90 subtypes, with genotype (GT) 3 being the second most common globally and is linked to higher incidences of steatosis and rapid development of fibrosis and cirrhosis. The NS3/4A serine protease, a heterodimer complex of two HCV non-structural proteins, is an effective target for pharmaceutical intervention due to its essential roles in processing HCV polyproteins and inhibiting innate immunity. This study combines structure-based virtual screening (SBVS) of predefined compound libraries, pharmacokinetic prediction (ADME/T) and in vitro evaluation to identify potential low molecular weight (
- Published
- 2021
19. Engineering Chikugunya vaccine based on the fusion of E2EP3 peptide into papaya mosaic virus nanoparticles
- Author
-
Hussin A. Rothan, Nurshamimi Nor Rashid, and Rohana Yusof
- Subjects
Microbiology (medical) ,chemistry.chemical_classification ,Fusion ,biology ,Nanoparticle ,Peptide ,General Medicine ,biology.organism_classification ,Virology ,lcsh:Infectious and parasitic diseases ,Infectious Diseases ,chemistry ,lcsh:RC109-216 ,Papaya mosaic virus - Published
- 2020
20. Docking, synthesis and bioassay studies of imine derivatives as potential inhibitors for dengue NS2B/ NS3 serine protease
- Author
-
Sharifuddin M. Zain, Heh Choon Han, Marzieh Yaeghoobi, Benni Iskandar, Rohana Yusof, Noorsaadah Abdul Rahman, and Neni Frimayanti
- Subjects
0301 basic medicine ,Microbiology (medical) ,030103 biophysics ,lcsh:Arctic medicine. Tropical medicine ,lcsh:RC955-962 ,viruses ,Imine ,lcsh:Medicine ,Dengue fever ,03 medical and health sciences ,chemistry.chemical_compound ,Dengue type 2 NS2B/NS3 ,Schiff base ,medicine ,Bioassay ,Serine protease ,NS3 ,biology ,Chemistry ,lcsh:R ,medicine.disease ,Infectious Diseases ,Biochemistry ,Docking (molecular) ,Molecular docking ,biology.protein - Abstract
Objective: To search imine derivatives as new active agents against dengue type 2 NS2B/NS3 using molecular docking, since there is no effective vaccine against flaviviral infections. Methods: In this research, molecular docking was performed for a series of imine derivatives and the information obtained from the docking studies was used to explore the binding modes of these imine derivatives with dengue type 2 NS2B/NS3 serine protease. A set of imine were synthesized and bioassay study of the inhibitory activities of these compounds was then performed. Results: The results indicated that MY8 and MY4 have the ability to inhibit DEN2 NS2B/NS3 proteolytic activity. Conclusions: These two compounds were chosen as the reference for the next stage in drug design as new inhibitor agents against NS2B/NS3.
- Published
- 2017
21. Molecular Docking Studies of Selected Medicinal Drugs as Dengue Virus-2 Protease Inhibitors
- Author
-
Saiful Anuar Karsani, Noorsaadah Abd Rahman, Nagasundara Ramanan Ramakrishnan, Rozana Othman, Aida Baharuddin, Rohana Yusof, and Rufaidah Othman
- Subjects
0301 basic medicine ,Multidisciplinary ,Protease ,Stereochemistry ,Chemistry ,medicine.medical_treatment ,In silico ,Allosteric regulation ,Dengue virus ,AutoDock ,medicine.disease_cause ,Meclofenamic acid ,03 medical and health sciences ,030104 developmental biology ,Catalytic triad ,medicine ,Rolitetracycline ,medicine.drug - Abstract
Dengue is a potentially deadly disease with no effective drug. An in silico molecular docking was performed using Autodock 4.2.6 to investigate the molecular interactions between protease inhibitors, comprising antibiotic derivatives namely doxycycline (3), rolitetracycline (5) and a non-steroidal anti-inflammatory drug (NSAID), meclofenamic acid (4), against the NS2B-NS3 protease from dengue virus-2 (DENV-2). The non-competitive inhibitor (3) showed lower binding energy (-5.15 kcal/mol) than the predicted competitive inhibitors 4 and 5 (-3.64 and -3.21 kcal/mol, respectively). Structural analyses showed compound 3 that bound to a specific allosteric site, interacted with Lys74, a significant amino acid residue bonded to one of the catalytic triad, Asp75. Compounds 4 and 5 showed direct binding with two of the catalytic triad, His51 and Ser135, hence, predicted to be competitive inhibitors.
- Published
- 2017
- Full Text
- View/download PDF
22. Kesejahteraan hidup warga emas: Perancangan berasaskan gender
- Author
-
Nurzalyna Mohamed Zaki, Shamzaeffa Samsudin, Rohana Yusof, Nur Syakiran Akmal Ismail, Norehan Abdullah, Ummu Atiyah Ahmad Zakuan, and Kalthum Hassan
- Abstract
Malaysia dijangka akan menghadapi fenomena menua tahun 2030. Pada tahun 2020 sahaja, warga tua di Malaysia dijangka mencecah 3.21 juta orang. Arus modenisasi banyak mengubah struktur keluarga di Malaysia sehingga perancangan masa hadapan dilihat penting dalam kehidupan. Pertimbangan dalam menempuh kehidupan waktu tua adalah penting untuk masa hadapan bagi mencapai kesejahteraan hidup. Kajian ini dilakukan bagi mengenalpasti keutamaan penyusunan hidup masa tua bagi lelaki dan wanita di Malaysia. Skop kajian ini meliputi tiga wilayah koridor ekonomi (NCER, ECER dan Iskandar) dan bancian yang dibuat terhadap bakal warga emas yang dipilih secara persampelan rawak berstrata. Sejumlah 1153 responden berbangsa Melayu yang terdiri daripada kumpulan umur 40-59 tahun telah berjaya diperolehi dan dianalisis secara deskriptif. Hasil kajian menunjukkan bahawa tiada perbezaan pilihan kehidupan masa tua antara lelaki dan wanita. Berbanding lelaki, responden wanita didapati lebih cenderung untuk tinggal bersama anak-anak berbanding tinggal bersendirian sebagai pilihan kedua. Responden lelaki tidak berminat untuk tinggal di institusi pondok, berbanding wanita yang menganggap tinggal di pondok sebagai salah satu alternatif pilihan hidup bagi meningkatkan pengetahuan agama mereka. Walau bagaimanapun, keseluruhan kajian menunjukkan responden lebih memberi keutamaan untuk tinggal di kediaman sendiri berdasarkan faktor keselesaan untuk diri mereka. Oleh itu, hasil kajian ini dapat menyumbang idea kepada pihak berwajib dalam merancang dasar-dasar yang sesuai untuk bakal warga emas masa hadapan.
- Published
- 2017
- Full Text
- View/download PDF
23. Conformational and energy evaluations of novel peptides binding to dengue virus envelope protein
- Author
-
Meilan Huang, Rohana Yusof, Rozana Othman, Shatrah Othman, Noorsaadah Abd Rahman, Asfarina Amir-Hassan, Aida Baharuddin, Yongtao Xu, and Vannajan Sanghiran Lee
- Subjects
0301 basic medicine ,Peptide ,Molecular Dynamics Simulation ,Dengue virus ,medicine.disease_cause ,Antiviral Agents ,01 natural sciences ,Molecular mechanics ,03 medical and health sciences ,symbols.namesake ,Molecular dynamics ,Viral Envelope Proteins ,Computational chemistry ,Materials Chemistry ,medicine ,Amino Acid Sequence ,Physical and Theoretical Chemistry ,Spectroscopy ,chemistry.chemical_classification ,Binding Sites ,010405 organic chemistry ,Chemistry ,Hydrogen Bonding ,Dengue Virus ,Entry into host ,Computer Graphics and Computer-Aided Design ,0104 chemical sciences ,Molecular Docking Simulation ,Dissociation constant ,030104 developmental biology ,Docking (molecular) ,symbols ,Biophysics ,Thermodynamics ,Protein Conformation, beta-Strand ,van der Waals force ,Peptides ,Protein Binding - Abstract
Effective novel peptide inhibitors which targeted the domain III of the dengue envelope (E) protein by blocking dengue virus (DENV) entry into target cells, were identified. The binding affinities of these peptides towards E-protein were evaluated by using a combination of docking and explicit solvent molecular dynamics (MD) simulation methods. The interactions of these complexes were further investigated by using the Molecular Mechanics-Poisson Boltzmann Surface Area (MMPBSA) and Molecular Mechanics Generalized Born Surface Area (MMGBSA) methods. Free energy calculations of the peptides interacting with the E-protein demonstrated that van der Waals (vdW) and electrostatic interactions were the main driving forces stabilizing the complexes. Interestingly, calculated binding free energies showed good agreement with the experimental dissociation constant (Kd) values. Our results also demonstrated that specific residues might play a crucial role in the effective binding interactions. Thus, this study has demonstrated that a combination of docking and molecular dynamics simulations can accelerate the identification process of peptides as potential inhibitors of dengue virus entry into host cells.
- Published
- 2017
- Full Text
- View/download PDF
24. Polycaprolactone Triol–Citrate Scaffolds Enriched with Human Platelet Releasates Promote Chondrogenic Phenotype and Cartilage Extracellular Matrix Formation
- Author
-
Simmrat Snigh, Rohana Yusof, Hussin A. Rothan, Ivan Djordjevic, Suhaeb A Mahmod, and Mojtaba Golpich
- Subjects
0301 basic medicine ,Cartilage oligomeric matrix protein ,biology ,Chemistry ,Cartilage ,Integrin ,Biomedical Engineering ,Medicine (miscellaneous) ,02 engineering and technology ,021001 nanoscience & nanotechnology ,Chondrogenesis ,Chondrocyte ,Cell biology ,Fibronectin ,Extracellular matrix ,03 medical and health sciences ,030104 developmental biology ,medicine.anatomical_structure ,Laminin ,biology.protein ,medicine ,Original Article ,0210 nano-technology ,Biomedical engineering - Abstract
In this paper we report the differentiating properties of platelet-rich plasma releasates (PRPr) on human chondrocytes within elastomeric polycaprolactone triol–citrate (PCLT–CA) porous scaffold. Human-derived chondrocyte cellular content of glycosaminoglycans (GAGs) and total collagen were determined after seeding into PCLT–CA scaffold enriched with PRPr cells. Immunostaining and real time PCR was applied to evaluate the expression levels of chondrogenic and extracellular gene markers. Seeding of chondrocytes into PCLT–CA scaffold enriched with PRPr showed significant increase in total collagen and GAGs production compared with chondrocytes grown within control scaffold without PRPr cells. The mRNA levels of collagen II and SOX9 increased significantly while the upregulation in Cartilage Oligomeric Matrix Protein (COMP) expression was statistically insignificant. We also report the reduction of the expression levels of collagen I and III in chondrocytes as a consequence of proximity to PRPr cells within the scaffold. Interestingly, the pre-loading of PRPr caused an increase of expression levels of following extracellular matrix (ECM) proteins: fibronectin, laminin and integrin β over the period of 3 days. Overall, our results introduce the PCLT–CA elastomeric scaffold as a new system for cartilage tissue engineering. The method of PRPr cells loading prior to chondrocyte culture could be considered as a potential environment for cartilage tissue engineering as the differentiation and ECM formation is enhanced significantly.
- Published
- 2017
- Full Text
- View/download PDF
25. Phytoestrogen (Daidzein) Promotes Chondrogenic Phenotype of Human Chondrocytes in 2D and 3D Culture Systems
- Author
-
Hussin A. Rothan, Simmrat Snigh, Thamil Selvee Ramasamy, Yong Mei Yee, Ivan Djordjevic, Suhaeb A Mahmod, and Rohana Yusof
- Subjects
0301 basic medicine ,endocrine system ,medicine.medical_specialty ,medicine.drug_class ,Biomedical Engineering ,Medicine (miscellaneous) ,Chondrocyte ,Extracellular matrix ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Laminin ,Internal medicine ,medicine ,030203 arthritis & rheumatology ,biology ,Daidzein ,food and beverages ,Chondrogenesis ,Fibronectin ,030104 developmental biology ,medicine.anatomical_structure ,Endocrinology ,chemistry ,Estrogen ,biology.protein ,Original Article ,Phytoestrogens - Abstract
Clinical investigations have shown a significant relationship between osteoarthritis (OA) and estrogens levels in menopausal women. Therefore, treatment with exogenous estrogens has been shown to decrease the risk of OA. However, the effect estrogen has not been clearly demonstrated in the chondrocytes using phytoestrogens, which lack the specific side-effects of estrogens, may provide an alternative therapy. This study was designed to examine the possible effects of phytoestrogen (daidzein) on human chondrocyte phenotype and extracellular matrix formation. Phytoestrogens which lack the specific side-effects of estrogens may provide beneficial effect without causing hormone based side effect. Human chondrocytes cells were cultured in 2D (flask) and 3D (PCL-CA scaffold) systems. Daidzein cytotoxic effect was determined by MTT assay. Chondrocyte cellular content of glycosaminoglycans (GAGs), total collagen and chondrogenic gene expression were determined in both culture systems after treatment with daidzein. Daidzein showed time-dependent and dose-independent effects on chondrocyte bioactivity. The compound at low doses showed significant (p 0.05). The expression levels of Fibronectin, Laminin and Integrin β1 were significantly increased especially in 3D culture system. This study was illustrated the potential positive effects of daidzein on maintenance of human chondrocyte phenotype and extracellular matrix formation suggesting an attractive and viable alternative therapy for OA.
- Published
- 2017
- Full Text
- View/download PDF
26. Antiviral and Virucidal activities of sulphated polysaccharides against Japanese Encephalitis Virus
- Author
-
Nurshamimi Nor Rashid, Rohana Yusof, and Hussin A. Rothan
- Subjects
medicine.drug_class ,viruses ,030231 tropical medicine ,Virus Attachment ,Biology ,Carrageenan ,Virus Replication ,Antiviral Agents ,Virus ,Cell Line ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,Humans ,Cytotoxic T cell ,MTT assay ,Cytotoxicity ,EC50 ,Encephalitis Virus, Japanese ,Virus Internalization ,Japanese encephalitis ,medicine.disease ,Virology ,In vitro ,Viral replication ,chemistry ,Rhodophyta ,Antiviral drug - Abstract
BackgroundJapanese encephalitis virus (JEV), a member of the family Flaviviridae, causes severe neurological disorders in humans. JEV infections represent one of the most widely spread mosquito-borne diseases, and therefore, it has been considered as an endemic disease. An effective antiviral drug is still unavailable to treat JEV, and current drugs only provide supportive treatment to alleviate the symptoms and stabilize patients’ conditions. This study was designed to evaluate the antiviral activity of the sulphated polysaccharides “Carrageenan,” a linear sulphated polysaccharide that is extracted from red edible seaweeds against JEV replication in vitro.Methods and ResultsViral inactivation, attachment, and post-infection assays were used to determine the mode of inhibition of Carrageenan. Virus titters after each application were evaluated by plaque formation assay. MTT assay was used to determine the 50% cytotoxic concentration (CC50), and ELISA-like cell-based assay and immunostaining and immunostaining techniques were used to evaluate the 50% effective concentration (EC50). This study showed that Carrageenan inhibited JEV at an EC50 of 15 μg/mL in a dose-dependent manner with CC50 more than 200 μg/mL in healthy human liver cells (WRL68). The mode of inhibition assay showed that the antiviral effects of Carrageenan are mainly due to their ability to inhibit the early stages of virus infection such as the viral attachment and the cellular entry stages.ConclusionOur investigation showed that Carrageenan could be considered as a potent antiviral agent to JEV infection. Further experimental and clinical studies are needed to investigate the potential applications of Carrageenan for clinical intervention against JEV infection.
- Published
- 2020
- Full Text
- View/download PDF
27. Endoplasmic reticulum: a focal point of Zika virus infection
- Author
-
Rohana Yusof, Muhammad Izzuddin Mohd Ropidi, Nurshamimi Nor Rashid, and Ahmad Suhail Khazali
- Subjects
Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Reticulophagy ,lcsh:Medicine ,Review ,Endoplasmic Reticulum ,Virus Replication ,Paraptosis ,Zika virus ,Unfolded protein response ,Humans ,Pharmacology (medical) ,Molecular Biology ,Endoplasmic reticulum ,Cytoplasmic vacuolization ,Stress granules ,Biochemistry, medical ,biology ,Zika Virus Infection ,lcsh:R ,Biochemistry (medical) ,Membrane Proteins ,Cell Biology ,General Medicine ,Translocon ,biology.organism_classification ,Endoplasmic Reticulum Stress ,Virology ,Flavivirus ,Viral replication ,Signal peptidase complex - Abstract
Zika virus (ZIKV) belongs to the Flavivirus genus of the Flaviviridae family. It is an arbovirus that can cause congenital abnormalities and is sexually transmissible. A series of outbreaks accompanied by unexpected severe clinical complications have captured medical attention to further characterize the clinical features of congenital ZIKV syndrome and its underlying pathophysiological mechanisms. Endoplasmic reticulum (ER) and ER-related proteins are essential in ZIKV genome replication. This review highlights the subcellular localization of ZIKV to the ER and ZIKV modulation on the architecture of the ER. This review also discusses ZIKV interaction with ER proteins such as signal peptidase complex subunit 1 (SPCS1), ER membrane complex (EMC) subunits, and ER translocon for viral replication. Furthermore, the review covers several important resulting effects of ZIKV infection to the ER and cellular processes including ER stress, reticulophagy, and paraptosis-like death. Pharmacological targeting of ZIKV-affected ER-resident proteins and ER-associated components demonstrate promising signs of combating ZIKV infection and rescuing host organisms from severe neurologic sequelae.
- Published
- 2020
28. Synthetic peptide optimization improves the inhibition of dengue NS2B-NS3 protease and dengue replication in vitro
- Author
-
Ahmad Suhail Khazali, A M Daher, Rohana Yusof, Hussin A. Rothan, Ammar Y. Abdulrahman, and T Ch Teoh
- Subjects
viruses ,medicine.medical_treatment ,Peptide ,Dengue virus ,medicine.disease_cause ,Virus Replication ,Antiviral Agents ,In vivo ,Virology ,medicine ,Humans ,Protease Inhibitors ,chemistry.chemical_classification ,Serine protease ,NS3 ,Protease ,biology ,Computational Biology ,General Medicine ,Dengue Virus ,In vitro ,Amino acid ,Enzyme Activation ,Infectious Diseases ,chemistry ,Biochemistry ,biology.protein ,Peptides - Abstract
Dengue virus (DENV) infection is one of the most widely-spread flavivirus infections with no effective antiviral drugs available. Peptide inhibitors have been considered as one of the best drug candidates due to their high specificity, selectivity in their interactions and minimum side effects. In this study, we employed computational studies using YASARA, HADDOCK server and PyMOL software to generate short and linear peptides based on a reference peptide, CP5-46A, to block DENV NS2B-NS3 protease. The inhibition potencies of the peptides were evaluated using in-house DENV2 serine protease and fluorogenic peptide substrates. In vitro analyses were performed to determine the peptides cytotoxicity and the inhibitory effects against DENV2 replication in WRL-68 cells. Our computational analyses revealed that the docking energy of AYA3, a 16 amino acid (aa) (-81.2 ± 10.6 kcal/mol) and AYA9, a 15 aa peptide (-83.8 ± 6.8 kcal/mol) to DENV NS2B-NS3 protease were much lower than the reference peptide (46 aa; -70.9 ± 7.8 kcal/mol) and the standard protease inhibitor, aprotinin (58 aa; -48.2 ± 10.6 kcal/mol). Both peptides showed significant inhibition against DENV2 NS2B-NS3 protease activity with IC50 values of 24 µM and 23 µM, respectively. AYA3 and AYA9 peptides also demonstrated approximately 68% and 83% of viral plaque reduction without significantly affecting cell viability at 50 µM concentration. In short, we generated short linear peptides with lower cytotoxic effect and substantial antiviral activities against DENV2. Further studies are required to investigate the inhibitory effects of these peptides in vivo. Keywords: peptide inhibitors; dengue virus; NS2B-NS3 protease; plaque reduction.
- Published
- 2019
29. Novel Quinazoline derivatives inhibited HCV Serine protease and viral replication in Huh-7 cells
- Author
-
Hussin A. Rothan, Fadhil Lafta Faraj, Teow Chong Teoh, and Rohana Yusof
- Subjects
Serine protease ,Quinazoline derivatives ,Protease ,biology ,Chemistry ,medicine.medical_treatment ,virus diseases ,Small molecule ,Virology ,digestive system diseases ,Viral replication ,medicine ,biology.protein ,IC50 ,Inhibitory effect ,Immunostaining - Abstract
Drugs against HCV infection are facing several drawbacks such as undesirable side effects, emerging of HCV resistant strains, and high cost of the entire course of treatment. Thus, new active and cost-effective compounds are required to develop effective drugs to combat HCV infection. This study was designed to test the antiviral activity of quinazoline derivatives against HCV infection using HCV protease assay (HCV NS3-4Apro) and cell-based HCV replicon assay. The results showed that some of quinazoline derivatives inhibited HCV NS3-4Apro with IC50 ranged from 42 µM of compound 4 to 150 µM of compound 2. In this study, compound 4 was considered as the best compound lead to developing potent anti-HCV NS3-4Apro inhibitors. The toxic dose of compound 4 was more than 80 µM for 24, 48, and 72 h. Compound 4 showed dose-dependent inhibition against HCV replication with a considerable reduction in Rluc activity at 40 µM. This finding was further investigated by immunostaining that showed the inhibitory effect of compound 4 against HCV NS3-4Apro was dose-dependent. This study identified a unique small molecule compound that could lead to the development of HCV NS3-A4pro inhibitors and would be useful to develop highly effective drugs for HCV infection based on HCV NS3-4A protease inhibition.
- Published
- 2019
- Full Text
- View/download PDF
30. Reconciling theory and practice on the participation of the downtrodden in poverty intervention policies and programs
- Author
-
Rohana Yusof and Abu Idris
- Subjects
Civil society ,Public economics ,Poverty ,media_common.quotation_subject ,05 social sciences ,Indoctrination ,010501 environmental sciences ,Public administration ,Formality ,01 natural sciences ,0506 political science ,Politics ,Intervention (law) ,Political science ,Elite ,050602 political science & public administration ,Empowerment ,0105 earth and related environmental sciences ,media_common - Abstract
The advocacy for the inclusion of community participation in policy process and consideration for the vox populi (voice of the people) in poverty intervention policies and programs has become a global mantra., Albeit, there are dearth of study that integrates theory and practice of participation to empirically test the effect of participation of the downtrodden on policies that affect them. This paper adopts mixed method to relate the theory and practice vis-a-vis examine the efficacy of participation of the downtrodden in poverty intervention programs in Niger state rural area. The quantitative findings indicate significant relationship between participation of the downtrodden in policy initiation and poverty reduction, while the qualitative result reveals that participation is theoretically faultless but empirically faultyit is elite dominating and more of indoctrination, political gimmick, deceit, pretense, and mere formality than reality. Resolutions where neither reflected in the policy agenda nor implemented. Consequently, participation of the downtrodden in policy is not suffice to alleviate poverty, thus, the study recommends for legal empowerment of an instituted advocacy group, featuring the Non-governmental organizations (NGOs) in the like of Civil Society Organization (CSO), dominant beneficiaries of intervention programs and stakeholders to checkmate the assumed excessive power of all and sundry connected to the intervention programs.
- Published
- 2016
- Full Text
- View/download PDF
31. Thioguanine-based DENV-2 NS2B/NS3 protease inhibitors: Virtual screening, synthesis, biological evaluation and molecular modelling
- Author
-
Nornisah Mohamed, Maywan Hariono, Noorsaadah Abd Rahman, Mei Lan Tan, Habibah A. Wahab, Mohamed Sufian Mohd. Nawi, Ezatul Ezleen Kamarulzaman, Ros Fatihah Roslim, Rohana Yusof, Shatrah Othman, Rozana Othman, and Sy Bing Choi
- Subjects
RNA viruses ,Viral Diseases ,medicine.medical_treatment ,Peptide ,Viral Nonstructural Proteins ,Dengue virus ,Pathology and Laboratory Medicine ,Molecular Dynamics ,medicine.disease_cause ,Biochemistry ,Physical Chemistry ,01 natural sciences ,Dengue Fever ,User-Computer Interface ,Chalcones ,Computational Chemistry ,Drug Stability ,Catalytic Domain ,Medicine and Health Sciences ,Free Energy ,chemistry.chemical_classification ,0303 health sciences ,Multidisciplinary ,biology ,Organic Compounds ,Chemistry ,Physics ,Serine Endopeptidases ,Proteases ,General Medicine ,Small molecule ,Enzymes ,Molecular Docking ,Molecular Docking Simulation ,Infectious Diseases ,Medical Microbiology ,Viral Pathogens ,Physical Sciences ,Viruses ,Thermodynamics ,Medicine ,Pathogens ,General Agricultural and Biological Sciences ,Research Article ,Neglected Tropical Diseases ,Stereochemistry ,Science ,Microbial Sensitivity Tests ,Molecular Dynamics Simulation ,Antiviral Agents ,Microbiology ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,medicine ,Humans ,Protease Inhibitors ,Thioguanine ,Microbial Pathogens ,030304 developmental biology ,NS3 ,Virtual screening ,Protease ,Chemical Bonding ,Flaviviruses ,Organic Chemistry ,Chemical Compounds ,Organisms ,Biology and Life Sciences ,Proteins ,Active site ,Hydrogen Bonding ,Dengue Virus ,Tropical Diseases ,Amides ,0104 chemical sciences ,010404 medicinal & biomolecular chemistry ,Enzymology ,biology.protein - Abstract
Dengue virus Type 2 (DENV-2) is predominant serotype causing major dengue epidemics. There are a number of studies carried out to find its effective antiviral, however to date, there is still no molecule either from peptide or small molecules released as a drug. The present study aims to identify small molecules inhibitor from National Cancer Institute database through virtual screening. One of the hits, D0713 (IC50 = 62 μM) bearing thioguanine scaffold was derivatised into 21 compounds and evaluated for DENV-2 NS2B/NS3 protease inhibitory activity. Compounds 18 and 21 demonstrated the most potent activity with IC50 of 0.38 μM and 16 μM, respectively. Molecular dynamics and MM/PBSA free energy of binding calculation were conducted to study the interaction mechanism of these compounds with the protease. The free energy of binding of 18 calculated by MM/PBSA is -16.10 kcal/mol compared to the known inhibitor, panduratin A (-11.27 kcal/mol), which corroborates well with the experimental observation. Results from molecular dynamics simulations also showed that both 18 and 21 bind in the active site and stabilised by the formation of hydrogen bonds with Asn174.
- Published
- 2019
32. <scp>AFN</scp> ‐1252 is a potent inhibitor of enoyl‐ <scp>ACP</scp> reductase from <scp> B </scp> urkholderia pseudomallei —Crystal structure, mode of action, and biological activity
- Author
-
Mohammed Takhi, Sarah Joseph, Noorsaadah Abd Rahman, Krishnamurthy N. Rao, Sheila Nathan, Kandepu Sreenivas, Swathi U. Lekshmi, Murali Ramachandra, Thomas Antony, Rohana Yusof, Ming Seong Lau, Hosahalli Subramanya, and Anirudha Lakshminarasimhan
- Subjects
chemistry.chemical_classification ,Melioidosis ,Burkholderia pseudomallei ,Biological activity ,Reductase ,Biology ,medicine.disease ,medicine.disease_cause ,biology.organism_classification ,Biochemistry ,Microbiology ,Enzyme ,chemistry ,Staphylococcus aureus ,medicine ,Antibacterial activity ,Mode of action ,Molecular Biology - Abstract
Melioidosis is a tropical bacterial infection caused by Burkholderia pseudomallei (B. pseudomallei; Bpm), a Gram-negative bacterium. Current therapeutic options are largely limited to trimethoprim-sulfamethoxazole and β-lactam drugs, and the treatment duration is about 4 months. Moreover, resistance has been reported to these drugs. Hence, there is a pressing need to develop new antibiotics for Melioidosis. Inhibition of enoyl-ACP reducatase (FabI), a key enzyme in the fatty acid biosynthesis pathway has shown significant promise for antibacterial drug development. FabI has been identified as the major enoyl-ACP reductase present in B. pseudomallei. In this study, we evaluated AFN-1252, a Staphylococcus aureus FabI inhibitor currently in clinical development, for its potential to bind to BpmFabI enzyme and inhibit B. pseudomallei bacterial growth. AFN-1252 stabilized BpmFabI and inhibited the enzyme activity with an IC50 of 9.6 nM. It showed good antibacterial activity against B. pseudomallei R15 strain, isolated from a melioidosis patient (MIC of 2.35 mg/L). X-ray structure of BpmFabI with AFN-1252 was determined at a resolution of 2.3 A. Complex of BpmFabI with AFN-1252 formed a symmetrical tetrameric structure with one molecule of AFN-1252 bound to each monomeric subunit. The kinetic and thermal melting studies supported the finding that AFN-1252 can bind to BpmFabI independent of cofactor. The structural and mechanistic insights from these studies might help the rational design and development of new FabI inhibitors.
- Published
- 2015
- Full Text
- View/download PDF
33. An Assessment of 'Zawarawa' Mass Marriage Programme, in Kano State, Nigeria
- Author
-
Amina Lawal Mashi and Rohana Yusof
- Subjects
Economic growth ,State (polity) ,media_common.quotation_subject ,Optometry ,Sociology ,media_common - Published
- 2015
- Full Text
- View/download PDF
34. LIVELIHOOD STRATEGIES AND INCOME GENERATING OPPORTUNITIES: A CASE STUDY ON RURAL POOR HOUSEHOLDS IN KEDAH, MALAYSIA
- Author
-
Rohana Yusof, Kalthum Hassan, and Norehan Abdullah
- Subjects
Economics and Econometrics ,Economic growth ,Poverty ,Interview ,Strategy and Management ,media_common.quotation_subject ,Qualitative property ,Livelihood ,Donation ,Economics ,Business and International Management ,Socioeconomics ,Welfare ,Finance ,media_common ,Collection methods - Abstract
The objectives of this paper are to uncover the livelihood strategies of the poor households in managing their incomes to sustain the household members’ welfare and whether the strategies can be translated as opportunities for poverty alleviation. Adopting qualitative data collection method, an in-depth interview method is used to retrieve information on the expenditure pattern of the households and the underlying reasons for doing so. Five households with various demographic backgrounds are chosen from Mukim Laka Temin, Kubang Pasu District. This study discovers the expenditure of each poor household is managed by a woman and each household has its own unique livelihood strategies which are based on the type of jobs of the household members and the households’ spending arrangements. All households prioritize their expenditure, food as the main priority, followed utility bills, transportation, education and others. Most households constantly receive financial supports from various sources such as government agencies and individuals in terms of zakat and donation. The study suggests the livelihoods strategies adopted by the households can be translated into opportunities for the poor households to improve their socio-economic status if the members receive proper provision of trainings and capitals.Keywords: Household Expenditure; Livelihood Strategies; Poor Households.
- Published
- 2017
- Full Text
- View/download PDF
35. Comparative proteomics reveals that YK51, a 4-Hydroxypandurantin-A analogue, downregulates the expression of proteins associated with dengue virus infection
- Author
-
Noorsaadah Abdul Rahman, Wei-Lian Tan, Yean Kee Lee, Saiful Anuar Karsani, Rohana Yusof, and Yen Fong Ho
- Subjects
0301 basic medicine ,Dengue virus type-2 ,Proteomics ,medicine.medical_treatment ,viruses ,lcsh:Medicine ,Biology ,Dengue virus ,medicine.disease_cause ,General Biochemistry, Genetics and Molecular Biology ,Virus ,Dengue fever ,03 medical and health sciences ,Evidence Based Medicine ,medicine ,Molecular Biology ,Dengue vaccine ,NS3 ,Protease ,030102 biochemistry & molecular biology ,General Neuroscience ,lcsh:R ,Inhibitory activity ,General Medicine ,medicine.disease ,Virology ,030104 developmental biology ,Infectious Diseases ,Proteome ,General Agricultural and Biological Sciences ,Anti-viral compound - Abstract
Dengue is endemic throughout tropical and subtropical regions of the world. Currently, there is no clinically approved therapeutic drug available for this acute viral infection. Although the first dengue vaccine Dengvaxia has been approved for use in certain countries, it is limited to those without a previous dengue infection while the safety and efficacy of the vaccine in those elderly and younger children still need to be identified. Therefore, it is becoming increasingly important to develop therapeutics/drugs to combat dengue virus (DENV) infection. YK51 is a synthetic analogue of 4-Hydroxypandurantin A (a compound found in the crude extract of the rhizomes of Boesenbergia rotunda) that has been extensively studied by our research group. It has been shown to possess outstanding antiviral activity due to its inhibitory activity against NS2B/NS3 DENV2 protease. However, it is not known how YK51 affects the proteome of DENV infected cells. Therefore, we performed a comparative proteomics analysis to identify changes in protein expression in DENV infected HepG2 cells treated with YK51. Classical two-dimensional gel electrophoresis followed by protein identification using tandem mass spectrometry was employed in this study. Thirty proteins were found to be down-regulated with YK51 treatment. In silico analysis predicted that the down-regulation of eight of these proteins may inhibit viral infection. Our results suggested that apart from inhibiting the NS2B/NS3 DENV2 protease, YK51 may also be causing the down-regulation of a number of proteins that may be responsible in, and/or essential to virus infection. However, functional characterization of these proteins will be necessary before we can conclusively determine their roles in DENV infection.
- Published
- 2017
36. NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy
- Author
-
Hussin A. Rothan, Rohana Yusof, Khadijeh Gholami, Fadihl L. Faraj, Mojtaba Golpich, Elham Amini, and Teow Chong Teoh
- Subjects
0301 basic medicine ,Male ,Indoles ,Plasma protein binding ,Pharmacology ,Hippocampus ,Receptors, N-Methyl-D-Aspartate ,Article ,Rats, Sprague-Dawley ,03 medical and health sciences ,Epilepsy ,0302 clinical medicine ,Seizures ,Malondialdehyde ,medicine ,Animals ,Binding site ,Receptor ,Multidisciplinary ,Chemistry ,medicine.disease ,Small molecule ,Molecular Docking Simulation ,Disease Models, Animal ,030104 developmental biology ,Docking (molecular) ,Quinazolines ,NMDA receptor ,Anticonvulsants ,Antagonism ,030217 neurology & neurosurgery ,Protein Binding - Abstract
N-methyl-D-aspartate receptors (NMDAR) play a central role in epileptogensis and NMDAR antagonists have been shown to have antiepileptic effects in animals and humans. Despite significant progress in the development of antiepileptic therapies over the previous 3 decades, a need still exists for novel therapies. We screened an in-house library of small molecules targeting the NMDA receptor. A novel indolyl compound, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, (DDBM) showed the best binding with the NMDA receptor and computational docking data showed that DDBM antagonised the binding sites of the NMDA receptor at lower docking energies compared to other molecules. Using a rat electroconvulsive shock (ECS) model of epilepsy we showed that DDBM decreased seizure duration and improved the histological outcomes. Our data show for the first time that indolyls like DDBM have robust anticonvulsive activity and have the potential to be developed as novel anticonvulsants.
- Published
- 2017
- Full Text
- View/download PDF
37. Fabrication and characterization of poly(octanediol citrate)/gallium-containing bioglass microcomposite scaffolds
- Author
-
Nahrizul Adib Kadri, Hussin A. Rothan, Mark R. Towler, Rohana Yusof, Sara Pourshahrestani, Ivan Djordjevic, Ehsan Zeimaran, and Belinda Pingguan-Murphy
- Subjects
chemistry.chemical_classification ,Materials science ,Mechanical Engineering ,Composite number ,technology, industry, and agriculture ,chemistry.chemical_element ,Osteoblast ,Dynamic mechanical analysis ,Polymer ,law.invention ,Contact angle ,medicine.anatomical_structure ,chemistry ,Chemical engineering ,Mechanics of Materials ,law ,Bioactive glass ,medicine ,General Materials Science ,Gallium ,Glass transition - Abstract
Bone can be affected by osteosarcomae requiring surgical excision of the tumor as part of the treatment regime. Complete removal of cancerous cells is difficult and conventionally requires the removal of a margin of safety around the tumor to offer improved patient prognosis. This work considers a novel series of composite scaffolds based on poly(octanediol citrate) (POC) impregnated with gallium-based bioglass microparticles for possible incorporation into bone following tumor removal. The objective of this research was to fabricate and characterize these scaffolds and subsequently report on their mechanical and biological properties. The porous microcomposite scaffolds with various concentrations of bioglass (10, 20, 30 wt%) incorporated were fabricated using a salt leaching technique. The scaffolds exhibited compression modulus in the range of 0.3–7 MPa. The addition of bioglass increased the mechanical properties even though porosity increased. Furthermore, increasing the concentration of bioglass had a significant influence on glass transition temperature from 2.5 °C for the pure polymer to around 25 °C for 30 % bioglass-containing composite. The ion release study revealed that composites containing 10 % bioglass had the highest ion release ratio after 28 days of soaking in phosphate buffered saline. The interaction of bioglass phase with POC led to the formation of additional ionic crosslinks aside from covalent crosslinks which further resulted in increased stiffness and decreased weight loss. The osteoblast cells were well attached and growth on composites and collagen synthesis increased particularly with the 10 % bioglass concentration.
- Published
- 2014
- Full Text
- View/download PDF
38. Synthesis and characterization of methacrylic microspheres for biomolecular recognition: Ultrasensitive biosensor for Dengue virus detection
- Author
-
Hussin A. Rothan, Rohana Yusof, Cees van der Marel, Fatimah Ibrahim, Ivan Djordjevic, Leo H. Koole, Abderazak Benzina, Samira Hosseini, RS: CARIM - R3 - Vascular biology, and Biomedische Technologie
- Subjects
Materials science ,Polymers and Plastics ,Organic Chemistry ,General Physics and Astronomy ,ELISA assay ,Methacrylic microspheres ,Antibody surface immobilization ,chemistry.chemical_compound ,Monomer ,chemistry ,Polymerization ,Methacrylic acid ,Covalent bond ,Polymer chemistry ,Materials Chemistry ,Dengue virus detection ,Methyl methacrylate ,Biosensor ,Macromolecule ,Carbodiimide - Abstract
In this paper we report methacrylic microspheres (MMS), produced via free-radical polymerization between methyl methacrylate (MMA) and methacrylic acid (MAA), cross-linked with triethylene glycol dimethacrylate (TEGDMA). In particular, MAA monomer was chosen for structural carboxyl functionalities that exist on the surface of produced microspheres. Two different MMA/MAA molar ratios of MMA TEGDMA MAA microspheres were processed effectively and both compositions of MMS were analyzed with scanning electron microscopy (SEM), optical microscopy and X-ray photoelectron spectroscopy (XPS). Results confirmed uniform surface morphology and two ranges of particle size distributions for different macromolecular structures. Surface carboxyl groups (generated from MAA polymer units) were used as polymeric platforms for immobilization of Dengue antibody molecules. In order to examine the efficiency of antibody surface immobilization we have performed fluorescence enzyme-linked immunosorbent assay (ELISA). Dengue antigens were used for specific recognition of template proteins (antibodies) and results show more than 20 times higher fluorescence intensity in comparison to conventional ELISA assay used in contemporary clinical practice. Furthermore, our results show that the physical adsorption of template antibodies is almost as effective as covalent attachment through carbodiimide chemistry and formation of amide bonds between amine peptide groups and surface carboxyl groups on microspheres.
- Published
- 2014
- Full Text
- View/download PDF
39. Three-Dimensional Culture Environment Increases the Efficacy of Platelet Rich Plasma Releasate in Prompting Skin Fibroblast Differentiation and Extracellular Matrix Formation
- Author
-
Noorsaadah Abd Rahmanh, Ivan Djordjevic, Mohammadjavad Paydar, Hirbod Bahrani, Hussin A. Rothan, Rohana Yusof, and Fatimah Ibrahim
- Subjects
Cellular differentiation ,Blotting, Western ,Cell Culture Techniques ,Real-Time Polymerase Chain Reaction ,Extracellular matrix ,Focal adhesion ,Laminin ,growth factors ,medicine ,Humans ,Viability assay ,Fibroblast ,Cells, Cultured ,Skin ,biology ,Platelet-Rich Plasma ,Cell Differentiation ,General Medicine ,human skin fibroblast ,Fibroblasts ,Molecular biology ,Extracellular Matrix ,Fibronectin ,medicine.anatomical_structure ,Cell culture ,biology.protein ,PCL-CA scaffold ,Microscopy, Electron, Scanning ,Platelet rich plasma ,Research Paper - Abstract
Platelet rich plasma clot- releasate (PRCR) shows significant influence on tissue regeneration in clinical trials. Although, the mechanism of PRCR effect on fibroblast differentiation has been studied on 2D culture system, a detailed investigation is needed to establish the role of PRCR in cell seeded in 3D scaffolds. Therefore, a study was conducted to evaluate the influence of PRCR in fibroblasts (DFB) differentiation and extracellular matrix formation on both 3D and 2D culture systems. Cell viability was measured using MTT assay and DFB differentiation was evaluated by determining the expression levels of nucleostamin and alpha smooth muscle actin (α-SMA), using indirect immunostaining and Western blotting. The expression levels of extracellular matrix genes (collagen-I, collagen-III, fibronectin and laminin) and focal adhesion formation gene (integrin beta-1) were measured using Real-time PCR. The PRCR at 10% showed significant effect on cells viability compared with 5% and 20% in both culture environments. The decrease in the expression levels of nucleostamin and the increase in α-SMA signify the DFB differentiation to myofibroblast-like cells that was prominently greater in 3D compared to 2D culture. In 3D culture systems, the total collage production, expression levels of the extracellular matrix gene and the focal adhesion gene were increased significantly compared to 2D culture. In conclusion, 3D culture environments enhances the proliferative and differentiation effects of PRCR on DFB, thereby potentially increases the efficacy of DFB for future tissue engineering clinical application.
- Published
- 2014
40. 1-Butyl-3-Methylimidazolium Chloride Ionic Liquid as Inhibitor for Corrosion Protection of Mild Steel in Acidic Media
- Author
-
S N.A. Syed Ismail, D Ahtoi, Amirah Amalina Ahmad Tarmizi, Duratul Ain Tholibon, L Peter, and Rohana Yusof
- Subjects
Environmental Engineering ,General Chemical Engineering ,General Engineering ,Chloride ,Corrosion ,chemistry.chemical_compound ,chemistry ,Hardware and Architecture ,Ionic liquid ,Computer Science (miscellaneous) ,medicine ,1-butyl-3-methylimidazolium ,Biotechnology ,Nuclear chemistry ,medicine.drug - Abstract
Corrosion inhibitor is a substance added to the corrosive environment in small quantities to reduce the corrosion a metal. The addition of inhibitors will reduce the corrosion rate of the metal by retarding the corrosion process on the metal surface. Thus, this study focused on the study of the effectiveness of 1- butyl-3-methylimidazolium chloride ([EMIM]Cl) ionic liquid as an inhibitor for corrosion protection of mild steel. Two different concentrations of [EMIM]Cl (0.05 M and 0.5 M) were tested into different concentrations of sulphuric acid (0.05M, 0.10 M, 0.15 M, 0.20 M and 0.25 M). Weight loss measurement was used to determine the effectiveness of the [EMIM]Cl as inhibitor for corrosion protection. Results showed that acid concentrations play an important role for the corrosion protection process in the presence of the inhibitor. The weight loss increases as the concentration of the acid increased. The study also revealed that the concentrations of [EMIM]Cl ionic liquid effect the performance of the inhibitor. From this study, 0.5 M of [EMIM]Cl ionic liquid shows better corrosion performance compared to 0.05 M of [EMIM]Cl. At 0.25 M of sulphuric acid, the weight loss of untreated metal increased drastically from 0.0075 g at 0.5 hour to 0.0974 g at 24 hours. After treated with 0.5 M of [EMIM]Cl, the weight loss measurement slightly increased from 0.0027 g at 0.5 hour to 0.0179 g at 24 hours. This weight loss value is lower compared to mild steel treated with 0.05 M [EMIM]Cl which is 0.0469 g at 24 hours. The performance of the inhibitor in two different type of acid was also investigated. The morphology of the untreated mild steel and mild steel treated with [EMIM]Cl was investigated by scanning electronic microscopy (SEM)
- Published
- 2019
- Full Text
- View/download PDF
41. Small molecule grp94 inhibitors block dengue and Zika virus replication
- Author
-
Mark A. Sanborn, Jingjing Ruan, Mark J. Henderson, Hussin A. Rothan, Teow Chong Teoh, Jun Hang, Yongwang Zhong, Shengyun Fang, and Rohana Yusof
- Subjects
0301 basic medicine ,Cell Survival ,viruses ,030106 microbiology ,Endoplasmic-reticulum-associated protein degradation ,Dengue virus ,Virus Replication ,medicine.disease_cause ,Antiviral Agents ,Article ,Dengue fever ,Zika virus ,Dengue ,03 medical and health sciences ,Ubiquitin ,Virology ,medicine ,Humans ,Oleanolic Acid ,Host factor ,Pharmacology ,Membrane Glycoproteins ,biology ,Zika Virus Infection ,virus diseases ,Zika Virus ,Dengue Virus ,medicine.disease ,biology.organism_classification ,Hsp90 ,Flavivirus ,030104 developmental biology ,biology.protein - Abstract
Two major flaviviruses, dengue virus (DENV) and Zika virus (ZIKV), cause severe health and economic burdens worldwide. Recently, genome-wide screenings have uncovered the importance of regulators of the Hrd1 ubiquitin ligase-mediated endoplasmic reticulum (ER)-associated degradation (ERAD) pathway for flavivirus replication in host cells. Here we report the identification of the compound Bardoxolone methyl (CDDO-me) as a potent inhibitor of the Hrd1 ubiquitin ligase-mediated ERAD, which possesses a broad-spectrum activity against both DENV and ZIKV. Cellular thermal shift assay (CETSA) suggested that CDDO-me binds to grp94, a key component of the Hrd1 pathway, at a low nanomolar concentration, whereas interaction was not detected with its paralog Hsp90. CDDO-me and the grp94 inhibitor PU-WS13 substantially suppressed DENV2 replication and the cytopathic effects caused by DENV and ZIKV infection. The antiviral activities of both compounds were demonstrated for all four DENV serotypes and four ZIKV strains in multiple human cell lines. This study defines grp94 as a crucial host factor for flavivirus replication and identified CDDO-me as a potent small molecule inhibitor of flavivirus infection. Inhibition of grp94 may contribute to the antiviral activity of CDDO-me. Further investigation of grp94 inhibitors may lead to a new class of broad-spectrum anti-flaviviral medications.
- Published
- 2019
- Full Text
- View/download PDF
42. Dengue Envelope Domain III-Peptide Binding Analysis via Tryptophan Fluorescence Quenching Assay
- Author
-
Meilan Huang, Rozana Othman, Rohana Yusof, Noorsaadah Abdul Rahman, Yongtao Xu, Aida Baharuddin, Bimo Ario Tejo, Shatrah Othman, and Asfarina Amir Hassan
- Subjects
chemistry.chemical_classification ,Ligand binding assay ,Tryptophan ,Peptide binding ,Peptide ,General Chemistry ,General Medicine ,Fluorescence ,Molecular biology ,Fluorescence spectroscopy ,law.invention ,chemistry ,law ,Drug Discovery ,Recombinant DNA ,Biophysics ,Electrophoretic mobility shift assay - Abstract
In the efforts to find an anti-viral treatment for dengue, a simple tryptophan fluorescence-screening assay aimed at identifying dengue domain III envelope (EIII) protein inhibitors was developed. Residue Trp391 of EIII was used as an intrinsic probe to monitor the change in fluorescence of the tryptophan residue upon binding to a peptide. The analysis was based on the electron excitation at 280 nm and fluorescence emission at 300-400 nm of EIII, followed by quenching of fluorescence in the presence of potential peptidic inhibitors coded DS36wt, DS36opt, DN58wt and DN58opt. The present study found that the fluorescence of the recombinant EIII was quenched following the binding of DS36opt, DN58wt and DN58opt in a concentration-dependent manner. Since the λmax for emission remained unchanged, the effect was not due to a change in the environment of the tryptophan side chain. In contrast, a minimal fluorescence-quenching effect of DS36wt at 20 and 40 µM suggested that the DS36wt does not have any binding ability to EIII. This was supported by a simple native-page gel retardation assay that showed a band shift of EIII domain when incubated with DS36opt, DN58wt and DN58opt but not with DS36wt. We thus developed a low-cost and convenient spectrophotometric binding assay for the analysis of EIII-peptide interactions in a drug screening application.
- Published
- 2014
- Full Text
- View/download PDF
43. Antiviral Cationic Peptides as a Strategy for Innovation in Global Health Therapeutics for Dengue Virus: High Yield Production of the Biologically Active Recombinant Plectasin Peptide
- Author
-
Hussin A. Rothan, Noorsaadah Abd Rahman, Rohana Yusof, Abdulrazzaq Mahmod Suhaeb, and Zulqarnain Mohamed
- Subjects
Staphylococcus aureus ,Cell Survival ,Recombinant Fusion Proteins ,medicine.medical_treatment ,Molecular Sequence Data ,Antimicrobial peptides ,Peptide ,Viral Nonstructural Proteins ,Dengue virus ,Biology ,Virus Replication ,medicine.disease_cause ,Antiviral Agents ,Biochemistry ,Microbiology ,law.invention ,law ,Chlorocebus aethiops ,Escherichia coli ,Genetics ,medicine ,Animals ,Amino Acid Sequence ,Vero Cells ,Molecular Biology ,Peptide sequence ,Inclusion Bodies ,chemistry.chemical_classification ,Protease ,Serine Endopeptidases ,Original Articles ,Dengue Virus ,Plectasin ,Virology ,Kinetics ,chemistry ,Factor Xa ,Vero cell ,Recombinant DNA ,Molecular Medicine ,Peptides ,Antimicrobial Cationic Peptides ,Biotechnology ,medicine.drug - Abstract
Dengue virus infects millions of people worldwide, and there is no vaccine or anti-dengue therapeutic available. Antimicrobial peptides have been shown to possess effective antiviral activity against various viruses. One of the main limitations of developing these peptides as potent antiviral drugs is the high cost of production. In this study, high yield production of biologically active plectasin peptide was inexpensively achieved by producing tandem plectasin peptides as inclusion bodies in E. coli. Antiviral activity of the recombinant peptide towards dengue serotype-2 NS2B-NS3 protease (DENV2 NS2B-NS3pro) was assessed as a target to inhibit dengue virus replication in Vero cells. Single units of recombinant plectasin were collected after applying consecutive steps of refolding, cleaving by Factor Xa, and nickel column purification to obtain recombinant proteins of high purity. The maximal nontoxic dose (MNTD) of the recombinant peptide against Vero cells was 20 μM (100 μg/mL). The reaction velocity of DENV2 NS2B-NS3pro decreased significantly after increasing concentrations of recombinant plectasin were applied to the reaction mixture. Plectasin peptide noncompetitively inhibited DENV2 NS2B-NS3pro at Ki value of 5.03 ± 0.98 μM. The percentage of viral inhibition was more than 80% at the MNTD value of plectasin. In this study, biologically active recombinant plectasin which was able to inhibit dengue protease and viral replication in Vero cells was successfully produced in E. coli in a time- and cost- effective method. These findings are potentially important in the development of potent therapeutics against dengue infection.
- Published
- 2013
- Full Text
- View/download PDF
44. Disruption of pocket protein dream complexes by E7 proteins of different types of human papillomaviruses
- Author
-
Roger J. Watson, Nurshamimi Nor Rashid, and Rohana Yusof
- Subjects
food.ingredient ,Papillomavirus E7 Proteins ,Plasma protein binding ,Alphapapillomavirus ,Biology ,Retinoblastoma Protein ,Risk category ,Tumor suppressor proteins ,food ,Virology ,Humans ,Tumor Suppressor Proteins ,Papillomavirus Infections ,Retinoblastoma protein ,virus diseases ,General Medicine ,female genital diseases and pregnancy complications ,In vitro ,Cell biology ,Infectious Diseases ,embryonic structures ,biology.protein ,biological phenomena, cell phenomena, and immunity ,Protein Binding - Abstract
It has been shown that the E7 protein of the high-risk HPV-16 transforms cells in vitro and binds pRB, p107 and p130, so called pocket proteins associated in cells with DREAM proteins, while that of the low-risk HPV-6 does not transform cells and binds p130 but not pRB or p107. These facts may indicate that p130 is essential for the HPV life cycle. To gain further insight into the relationship between HPV E7 proteins and pocket protein-DREAM complexes, E7 proteins of HPVs of various risk categories were expressed via appropriate vectors in T98G cells and the levels of various pocket proteins either total or associated with DREAM were analyzed. The obtained results demonstrated that high-risk HPV-16, HPV-18 and HPV-33, low-risk HPV-1 and HPV-11, and cutaneous HPV-48 disrupted pocket protein-DREAM complexes in T98G cells to a similar extent.
- Published
- 2013
- Full Text
- View/download PDF
45. Boesenbergia rotunda: From Ethnomedicine to Drug Discovery
- Author
-
Shatrah Othman, Chee Chin-Fei, Norzulaani Khalid, Foo Gen-Teck, Rozana Othman, Saiful Anuar Karsani, Tan Eng-Chong, Wong Sher-Ming, Heh Choon-Han, Lee Yean-Kee, Noorsaadah Abd Rahman, Rohana Yusof, and Christina Thio Li-Ping
- Subjects
food.ingredient ,biology ,Traditional medicine ,Drug discovery ,Review Article ,lcsh:Other systems of medicine ,lcsh:RZ201-999 ,biology.organism_classification ,Boesenbergia ,Synthetic drugs ,food ,Complementary and alternative medicine ,Asian country ,Rotunda ,Polypharmacology ,Ethnomedicine ,Boesenbergia rotunda - Abstract
Boesenbergia rotundais a herb from theBoesenbergiagenera under the Zingiberaceae family.B. rotundais widely found in Asian countries where it is commonly used as a food ingredient and in ethnomedicinal preparations. The popularity of its ethnomedicinal usage has drawn the attention of scientists worldwide to further investigate its medicinal properties. Advancement in drug design and discovery research has led to the development of synthetic drugs fromB. rotundametabolites via bioinformatics and medicinal chemistry studies. Furthermore, with the advent of genomics, transcriptomics, proteomics, and metabolomics, new insights on the biosynthetic pathways ofB. rotundametabolites can be elucidated, enabling researchers to predict the potential bioactive compounds responsible for the medicinal properties of the plant. The vast biological activities exhibited by the compounds obtained fromB. rotundawarrant further investigation through studies such as drug discovery, polypharmacology, and drug delivery using nanotechnology.
- Published
- 2012
- Full Text
- View/download PDF
46. Antiviral actions of flavanoid-derived compounds on dengue virus type-2
- Author
-
Mudiana Muhamad, Lee Yean Kee, Noorsaadah Abd. Rahman, Rohana Yusof
- Subjects
lcsh:Biology (General) ,lcsh:QH301-705.5 - Abstract
Dengue viruses, mosquito-borne members of the Flaviviridae family, are the causative agents of dengue fever and its associated complications, dengue haemorrhagic fever and dengue shock syndrome. To date, more than 2.5 billion people in over 100 countries are at risk of infection, and approximately 20 million infections were reported annually. There is currently no treatment or vaccine available for dengue infection. This study employed a whole-cell organism model or in vitro methods to study the inhibitory property of the flavanoid-derived compounds against DENV2 activity. Results showed that at concentration not exceeding the maximum non-toxic dose (MNTD), these compounds completely prevented DENV2 infection in HepG2 cells as indicated by the absence of cytophatic effects. The in vitro antiviral activity assessed in HepG2 cells employing virus inhibition assay showed high inhibitory activity in a dose dependent manner. At concentration below MNTD, compounds exhibited inhibitory activity against DENV2 with a range of potency strengths of 72% to 100%. The plaque forming unit per ml (pfu/ml) was reduced prominently with a maximum reduction of 98% when the infected HepG2 cells were treated with the highest non-toxic dose of compounds. The highly potent activity of the compounds against DENV2 infection strongly suggests their potential as a lead antiviral agent for dengue.
- Published
- 2010
47. HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block
- Author
-
Roger J. Watson, Nurshamimi Nor Rashid, Rohana Yusof, and Zi Ling Yong
- Subjects
Retinoblastoma like protein 2 (RBL2) ,0301 basic medicine ,Cell cycle checkpoint ,Pocket protein family ,Papillomavirus E7 Proteins ,Amino Acid Motifs ,Short Report ,Alphapapillomavirus ,Biology ,03 medical and health sciences ,0302 clinical medicine ,DREAM complex ,Virology ,Humans ,Protein Interaction Domains and Motifs ,Amino Acid Sequence ,E2F ,Human papillomavirus E7 oncoprotein ,S phase ,p130 ,Retinoblastoma-Like Protein p130 ,Papillomavirus Infections ,Cyclin-dependent kinase 2 ,Cell Cycle Checkpoints ,Cell cycle ,030104 developmental biology ,Infectious Diseases ,030220 oncology & carcinogenesis ,Mutation ,embryonic structures ,Cervical cancer ,biology.protein ,biological phenomena, cell phenomena, and immunity ,Protein Binding - Abstract
Background Retinoblastoma like protein 2 (RBL2) or p130 is a member of the pocket protein family, which is infrequently mutated in human tumours. Its expression is posttranscriptionally regulated and largely G0 restricted. We have previously shown that E6/E7 oncoproteins encoded by human papillomavirus (HPV) type 16, which is a high-risk type for cervical cancer development, must target p130 to promote the host cell to exit from quiescence (G0) state and enter S phase of the cell cycle. P130 is associated with the DREAM (DP, RB-like, E2F and MuvB) complex in G0/G1, which prevents S phase progression by repressing transcription of E2F-regulated genes. E7 proteins could potentially disrupt the p130-DREAM complex through two known mechanisms: direct interaction with p130 or induction of cyclin dependent kinase 2 (CDK2) phosphorylation by interacting with its inhibitor, p21CIP1. Methods In this study we have used p130 mutants deficient in binding the E7 LXCXE domain (p130mE7), unphosphorylatable by CDK2 (p130PM22) or a combination of both (p130PM22/mE7) to investigate these mechanisms used by E7 proteins to disrupt the p130-DREAM complex and promote cell cycle progression. Results We found that HPV16 E7 binding to p130 through its LXCXE domain was absolutely required to disrupt p130-DREAM to promote S phase of the cell cycle, as HPV16 E7 was unable to suppress p130mE7 but could suppress p130PM22. In contrast, the E7 protein encoded by a cutaneous HPV type that lacks a functional LXCXE domain, HPV 48 E7, was also able to disrupt p130-DREAM to promote cell cycling, but through the alternative mechanism. Thus, HPV48 E7 could suppress a cell cycle block imposed by p130mE7, but was unable to suppress p130PM22. Conclusions Overall, these results indicate that suppression of p130 is required for HPV-induced cell cycling, and that different HPV E7 proteins can use alternative mechanisms to achieve this. Electronic supplementary material The online version of this article (doi:10.1186/s12985-015-0460-8) contains supplementary material, which is available to authorized users.
- Published
- 2016
- Full Text
- View/download PDF
48. Democracy and Rural Development in Nigeria’s Fourth Republic: Challenges and Prospect
- Author
-
Suyatno, Rohana Yusof, and Abdulrazak Yuguda Madu
- Subjects
education.field_of_study ,Government ,Economic growth ,Rural dwellers ,General Arts and Humanities ,media_common.quotation_subject ,Population ,General Social Sciences ,Dictatorship ,Democracy ,Independence ,Rural development ,lcsh:Social Sciences ,lcsh:H ,Development economics ,Economics ,education ,General Economics, Econometrics and Finance ,Developed country ,media_common - Abstract
Nigeria’s return to democratically elected government in 1999; after decades of Military rule and dictatorship since independence in 1960 has placed the country’s agenda on an agreed target by all and sundry, and this was accompanied by hopes, aspirations and expectations, due to the fact that, the countries development remains inadequate, most especially at the rural level which is regarded as most deprived and undeveloped. This paper therefore, attempts to examine the challenges and prospects of democracy on rural development in Nigeria from 1999-2014. The methodologies adopted in obtaining data for the paper are purely empirical and secondary. The paper contends that, democratic performance to bringing the desired changes and development in Nigeria remained abysmal and insignificant. It was concluded that for democracy to be meaningful; rural dwellers which accounted for the bulk of the country’s population must be developed otherwise the counties strides to been among one of the developed nations will remain a mirage and unattained. DOI: 10.5901/mjss.2015.v6n6s4p445
- Published
- 2015
49. Microsphere integrated microfluidic disk: synergy of two techniques for rapid and ultrasensitive dengue detection
- Author
-
Abderazak Benzina, Marc J. Madou, Ivan Djordjevic, Shah Mukim Uddin, Mohammad Mahdi Aeinehvand, Rohana Yusof, Samira Hosseini, Fatimah Ibrahim, Leo H. Koole, Hussin A. Rothan, School of Materials Science & Engineering, RS: CARIM - R3 - Vascular biology, and Biomedische Technologie
- Subjects
Bioanalysis ,Analyte ,Time Factors ,Materials science ,Microfluidics ,Enzyme-Linked Immunosorbent Assay ,Nanotechnology ,Dengue virus ,medicine.disease_cause ,Sensitivity and Specificity ,Article ,Microsphere ,Dengue ,Polymethacrylic Acids ,medicine ,Humans ,Particle Size ,Detection limit ,Multidisciplinary ,Reproducibility of Results ,Dengue Virus ,Microfluidic Analytical Techniques ,Molecular biology ,Microspheres ,Micromixing ,Methacrylates ,Signal amplification - Abstract
The application of microfluidic devices in diagnostic systems is well-established in contemporary research. Large specific surface area of microspheres, on the other hand, has secured an important position for their use in bioanalytical assays. Herein, we report a combination of microspheres and microfluidic disk in a unique hybrid platform for highly sensitive and selective detection of dengue virus. Surface engineered polymethacrylate microspheres with carefully designed functional groups facilitate biorecognition in a multitude manner. In order to maximize the utility of the microspheres’ specific surface area in biomolecular interaction, the microfluidic disk was equipped with a micromixing system. The mixing mechanism (microballoon mixing) enhances the number of molecular encounters between spheres and target analyte by accessing the entire sample volume more effectively, which subsequently results in signal amplification. Significant reduction of incubation time along with considerable lower detection limits were the prime motivations for the integration of microspheres inside the microfluidic disk. Lengthy incubations of routine analytical assays were reduced from 2 hours to 5 minutes while developed system successfully detected a few units of dengue virus. Obtained results make this hybrid microsphere-microfluidic approach to dengue detection a promising avenue for early detection of this fatal illness.
- Published
- 2015
- Full Text
- View/download PDF
50. Simple one-medium formulation regeneration of fingerroot [Boesenbergia rotunda (L.) mansf. Kulturpfl.] via somatic embryogenesis
- Author
-
Halijah Ibrahim, Rohana Yusof, Noorsaadah Abd Rahman, Noorzulaani Khalid, Richard Pippen, and S. K. Tan
- Subjects
Kaempferia ,food.ingredient ,biology ,Somatic embryogenesis ,Plant Science ,biology.organism_classification ,Boesenbergia ,Horticulture ,Murashige and Skoog medium ,food ,Micropropagation ,Callus ,Botany ,Biotechnology ,Boesenbergia rotunda ,Explant culture - Abstract
Most published protocols necessitate different media formulations for multistep somatic embryogenesis. This study aims to establish a simple but effective formulation for the regeneration of plantlets of the pharmaceutically active Boesenbergia rotunda (L.) Mansf. Kulturpfl, formerly Boesenbergia/Kaempferia pandurata (Schult), to ensure a superior and consistent supply of materials for commercialization purposes. In this study, a single-medium formulation of Murashige and Skoog (MS) supplemented with 13.54 μM 2,4-dichlorophenoxyacetic acid (2,4-D) was found to be the only medium out of eight formulations to promote the complete somatic embryogenesis process for the culture of B. rotunda (L.). Callus cultures were initiated from a total of 280 explants of rhizome meristem. The percentage of cultures forming embryogenic callus was 23.3 ± 4.3% on this MS medium augmented by 13.54 μM 2,4-D. The best plantlet regeneration rate was attained from the first subcultured callus with a mean of 6.6 ± 0.1 pla...
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.